Literature DB >> 20674700

Carcinoma of the urethra: radiation oncology.

Bridget F Koontz1, W Robert Lee.   

Abstract

Urethral cancer is a rare but aggressive neoplasm. Early-stage distal lesions can be successfully treated with a single modality. Results for definitive radiotherapy using either or both external beam radiation therapy and brachytherapy have shown excellent cure rates in men and women. The primary advantage of radiotherapy is organ preservation. Advanced tumors, however, have poor outcomes with single modality treatment. Results have been improved using a combination of radiotherapy and chemotherapy, chiefly 5-fluorouracil and mitomycin C. Although literature is limited to case reports because of the rarity of the disease, the markedly improved results compared with older results of surgery with or without radiation warrant consideration. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20674700     DOI: 10.1016/j.ucl.2010.04.007

Source DB:  PubMed          Journal:  Urol Clin North Am        ISSN: 0094-0143            Impact factor:   2.241


  3 in total

1.  Intraluminal urethral brachytherapy for recurrence of transitional cell carcinoma of urinary bladder in urethral stump.

Authors:  Bikramjit Chakrabarti; Suman Ghorai; Somapriya Basu Ray; Sanjay Kumar Kar
Journal:  J Contemp Brachytherapy       Date:  2013-03-29

Review 2.  Current Perspectives on the Diagnosis and Management of Primary Urethral Cancer: A Systematic Review.

Authors:  M Ryan Farrell; Jonathan T Xu; Alex J Vanni
Journal:  Res Rep Urol       Date:  2021-06-01

3.  Successful treatment of a 67-year-old woman with urethral adenocarcinoma with the use of external beam radiotherapy and image guided adaptive interstitial brachytherapy.

Authors:  Jasmin Mujkanovic; Kari Tanderup; Mads Agerbæk; Ulla Bisgaard; Søren Høyer; Jacob Christian Lindegaard; Lars Fokdal
Journal:  J Contemp Brachytherapy       Date:  2016-11-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.